Why is "SARS-CoV-2 Omicron variant" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-11 10:49:05
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Omicron (B.1.1.529) is a heavily mutated variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. Following the original B.1.1.529 variant, several subvariants of Omicron have emerged, including: BA.1, BA.2, BA.3, BA.4, and BA.5. Two subvariants of BA.5 emerged by October 2022, called BQ.1 and BQ.1.1.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant - Nature
-
New Full-Length Synthetic Genome of the SARS-CoV-2 Omicron Variant - Lab Manager
-
Lung Transplant Recipients at High Risk of Secondary Lung Infections Post Infection With SARS-CoV-2 Omicron Variant - Pharmacy Times
-
Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - The New England Journal of Medicine
-
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex - Science | AAAS
-
Notes from the Field: SARS-CoV-2 Omicron Variant Infection... - Centers for Disease Control and Prevention | CDC (.gov)
-
Antiviral effect of Bromelain combined with acetylcysteine against SARS-CoV-2 Omicron variant - Nature
-
Plasma Neutralization of the SARS-CoV-2 Omicron Variant - The New England Journal of Medicine
-
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - Nature
-
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination - The New England Journal of Medicine
-
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature
-
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons - The New England Journal of Medicine
-
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa - Nature
-
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination - Nature
-
Household transmission of the SARS-CoV-2 Omicron variant in Denmark - Nature
-
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark - Nature
-
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination - Nature
-
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant - Nature
-
SARS-CoV-2 Omicron variant emerged under immune selection - Nature
-
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant - Nature
-
RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa - Science | AAAS
-
SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters - Nature
-
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C - Nature
-
Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters - Nature
-
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study - The Lancet
-
Antibodies recognize new SARS-CoV-2 Omicron variant after booster - National Institutes of Health (.gov)
-
Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian province: a retrospective study - Nature
-
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant - Nature
-
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1 - ASM Journals
-
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations | Communications Biology - Nature
-
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant - Nature
-
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination - Nature
-
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model - Nature
-
Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant - Nature
-
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant - Nature
-
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment - Nature
-
Treating SARS-CoV-2 Omicron variant infection by molnupiravir for pandemic mitigation and living with the virus: a mathematical modeling study - Nature
-
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization (WHO)
-
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant - Nature
-
Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209 - Nature
-
Multiple-cohort study of the elderly to determine the immunological characteristics and pathogenic mechanisms of severe community-acquired pneumonia caused by the low-virulence virus SARS-CoV-2 Omicron variant | Cell Discovery - Nature
-
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding - Nature
-
Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma - Taylor & Francis Online
-
Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor - Nature
-
Comparative spatial–temporal analysis of SARS-CoV-2 lineages B.1.1.33 and BQ.1.1 Omicron variant across pandemic phases - Nature
-
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations - Nature
-
Outcomes of the SARS–CoV-2 Omicron Variant Outbreak Among European Patients With Cancer - The ASCO Post
-
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant - Nature
-
Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023 - Nature
-
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant - Nature
-
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant - Nature
-
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant - Nature
-
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection - The New England Journal of Medicine
-
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination - Nature
-
A pattern shift in SARS-CoV-2 Omicron variant transmission after the city lockdown--observational study based upon daily reported addresses of infected cases - medRxiv
-
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination - Nature
-
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant - Nature
-
SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine - Wiley Online Library
-
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron - Nature
-
Clinical advancement of patients infected with SARS-CoV-2 Omicron variant in Shanghai, China - medRxiv
-
T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature
-
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity - Nature
-
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway - Nature
-
Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant - Taylor & Francis Online
-
Recent insights into SARS‐CoV‐2 omicron variant - Silva - 2023 - Reviews in Medical Virology - Wiley Online Library
-
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance - Nature
-
Does the SARS-CoV-2 omicron variant have specific CT signs? - AuntMinnie
-
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection - Wiley Online Library
-
Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses - Wiley Online Library
-
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination | New England Journal of Medicine - The New England Journal of Medicine
-
AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization - News-Medical
-
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages - Nature
-
SARS-CoV-2 Omicron variant: What we know so far - News-Medical
-
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine
-
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants - Nature
-
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection - Nature
-
Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant - News-Medical
-
The emergence of new SARS-CoV-2 omicron subvariants introduces uncertainty about the end of the COVID-19 pandemic - Frontiers
-
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants | New England Journal of Medicine - The New England Journal of Medicine
-
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations - Nature
-
Molecular Insights into Striking Antibody Evasion of SARS-CoV-2 Omicron Variant - IOPscience
-
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue - Nature
-
Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals – From the First Wave to the Omicron Variant - Frontiers
-
SARS-CoV-2 variant biology: immune escape, transmission and fitness - Nature
-
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study - The Lancet
-
Efficacy of booster messenger ribonucleic acid COVID-19 vaccinations against SARS-CoV-2 Omicron variant severity - News-Medical
-
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose - The Lancet
-
Recent insights into SARS‐CoV‐2 omicron variant - Silva - 2023 - Reviews in Medical Virology - Wiley Online Library
-
Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation - Nature
-
The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals - Frontiers
-
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 - The New England Journal of Medicine
-
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 - Nature
-
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults - Nature
-
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum - The Lancet
-
Molecular basis of receptor binding and antibody neutralization of Omicron - Nature
-
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation - Nature
-
Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters - Nature
-
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus - Nature
-
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 - Centers for Disease Control and Prevention | CDC (.gov)
-
Antibody evasion properties of SARS-CoV-2 Omicron sublineages - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.